Bevacizumab therapy and multimodal ultrawide-field imaging in immunogammopathy maculopathy secondary to Waldenström's macroglobulinemia.
Ophthalmic Surg Lasers Imaging Retina
; 46(2): 262-5, 2015 Feb.
Article
in En
| MEDLINE
| ID: mdl-25707055
ABSTRACT
Waldenström's macroglobulinemia (WM) is associated with retinal findings of hyperviscosity, such as venous dilation, and findings of immunogammopathy maculopathy, such as serous macular detachment. This report describes a case of bilateral serous macular detachment with intraretinal schisis-like fluid in a patient with WM. Enhanced depth imaging optical coherence tomography revealed a thickened choroid with hyperreflective accumulations in the retinal pigment epithelium layer. Ultrawide-field fundus autofluorescence demonstrated a central area of hyperautofluorescence corresponding to the area of serous macular detachment. Ultrawide-field fluorescein angiography was characteristically silent. Intravitreal bevacizumab therapy resulted in significant reduction in intraretinal fluid but minimal change in subretinal fluid. Long-term follow-up demonstrated alterations in retinal architecture and improved serous detachments.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Monoclonal Gammopathy of Undetermined Significance
/
Retinal Detachment
/
Immunoglobulin M
/
Waldenstrom Macroglobulinemia
/
Angiogenesis Inhibitors
/
Antibodies, Monoclonal, Humanized
/
Multimodal Imaging
Type of study:
Diagnostic_studies
/
Etiology_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ophthalmic Surg Lasers Imaging Retina
Year:
2015
Type:
Article